PURE Bioscience (OTCMKTS:PURE – Get Free Report) was the target of a large drop in short interest in the month of October. As of October 15th, there was short interest totaling 4,381 shares, a drop of 77.3% from the September 30th total of 19,268 shares. Based on an average trading volume of 65,650 shares, the short-interest ratio is presently 0.1 days. Approximately 0.0% of the company’s shares are short sold.
PURE Bioscience Price Performance
Shares of PURE traded up $0.00 during midday trading on Wednesday, hitting $0.07. The company had a trading volume of 11,100 shares, compared to its average volume of 31,727. The company’s 50 day moving average price is $0.07 and its 200 day moving average price is $0.07. PURE Bioscience has a 52 week low of $0.04 and a 52 week high of $0.10.
About PURE Bioscience
PURE Bioscience, Inc develops and commercializes antimicrobial products based on its proprietary silver dihydrogen citrate (SDC) technology. SDC is designed to provide broad-spectrum antimicrobial activity and is used as an active ingredient in formulations intended for applications such as surface disinfection, sanitation and odor control.
The company’s product portfolio has included PureGreen24, a disinfectant and sanitizer marketed for use on hard, nonporous surfaces in commercial, institutional, industrial and residential settings.
See Also
- Five stocks we like better than PURE Bioscience
- Want to Own a Piece of Professional Sports? This ETF Could Be Your Ticket
- Welltower’s Strong Earnings Couldn’t Stop the Sell-Off—What’s Missing?
- Sherwin-Williams Remains Evergreen in a Frozen Housing Market
- Palantir’s Q3 Bar Is Higher Than It Looks: 3 Numbers to Watch
Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
